Yep, 'really going there'. I was in medical sales for a

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks cashclan #23348
Yep, 'really going there'. I was in medical sales for a portion of my career, but I had no illusions about being what we called a 'toy doctor.'

Neither of us is an obstetrician, but only one of us does not rely on personal anecdotes over actual data on this issue

And of course only one of us does not presume to know all circumstances that can confront individuals and families.

You continue to avoid just what you want to do enforce an abrogation of Roe V Wade.

What would the new laws state and how exactly would you enforce them?

This is what an 'informed opinion', from a doctor, based upon both facts and experience, looks like:

Quote:
The Medical Complexity of “Late-Term” Abortions

The rhetoric employed by Donald Trump refuses to recognize the reality of these situations.

By Phoebe Day Danziger

Dr. Phoebe Danziger is a resident physician in pediatrics. She lives in Ann Arbor, Michigan.

=When asked about late-term abortion at Wednesday night’s debate, Donald Trump provided a nonsensical, non-reality-based description.

Wednesday night, most of America heard Donald Trump and Hillary Clinton discuss, among other things, late-term abortion. Their positions came as no surprise. Clinton reiterated her position that late-term abortions, which are performed in cases of severe maternal or fetal complications, represent heart-wrenching, intimate decisions that must be protected.

Trump provided a nonsensical, non-reality-based description and condemnation of full-term infants being “ripped out of the womb … in the ninth month on the final day” and declared his intention to have the constitutional right to abortion overturned.

Sometimes these decisions are made after their children are born. Others must be made when their children are still in utero.

As a pediatric resident at a major academic medical center, I have the privilege of working day in and day out with a remarkably diverse population of children, including countless children born with congenital anomalies such as structural heart disease, genetic disorders such as trisomy 18 and cystic fibrosis, and significant injuries sustained in utero such as perinatal strokes.

The treatments these patients receive are incredible: There are phenomenally complex staged cardiothoracic surgeries performed on inconceivably tiny hearts and great vessels.

And highly controlled whole-body cooling that drastically improves the neurologic outcomes for some babies born with hypoxic-ischemic injury.

Some of these babies go on to have remarkably meaningful, productive lives. Others will die as infants while receiving palliative and hospice care, or while receiving attempts at life-prolonging care.

Some will continue to grow with significant neurologic and developmental deficits, and will be dependent on their caregivers for some or all activities of daily living. Some can smile, grasp the string of a balloon or a rattle, and laugh.

Some have tracheostomies and require mechanical ventilation, with homes equipped with oxygen and back-up oxygen and power generators. Others are on dialysis and waiting for a kidney transplant. Some “beat the odds.” Some don’t.

Many families feel that every moment with their child is meaningful, and that it is worth any cost—financial, psychological, logistical—to pursue all possible life-sustaining treatment. Other families judge their child’s quality of life to be such that the benefits of life-prolonging care do not, to them, outweigh the risks and burdens.

Some, knowing what they know now, would go back and choose not to continue their pregnancy. Others may wonder what would have happened had they chose to go on.

The decisions that these families make about their children are extremely complex, personal, and often painful. Sometimes these decisions are made after their children are born. Sometimes these decisions must be made when their children are still in utero. This is the reality of late-term maternal and fetal complications. They are heartbreaking in both circumstances.

I once had to make such a decision. I am the mother of three healthy daughters, and one son who was never born. As I have written previously, I had an abortion halfway through my pregnancy when our baby was diagnosed with a severe lower urinary tract obstruction.

His prognosis was uncertain but poor. For so many reasons, including a desire for our baby not to suffer and concern for the psychological well-being of our family, we chose to terminate the pregnancy.

This was a personal decision. It was a complex decision. It should not have been illegal, any more than a parent should not be allowed to decide, based on medical advice, to move a sick and suffering child into palliative care.

And still as a society, we are unable to talk about the reality of these situations in a logical, fact-based manner.

During the debate Trump was asked about his position on late-term and partial-birth abortions. Never mind that these kinds of abortions represent a vast minority of abortions performed in this country. That they are performed in exceptional circumstances characterized by serious threat to the health of the mother or the fetus. That the very terms used to describe them—late-term abortions and partial-birth abortions—aren’t even medically valid.

Never mind all of that. Here is what Trump said:

If you go with what Hillary is saying, in the ninth month, you can take the baby and rip the baby out of the womb of the mother just prior to the birth of the baby.

Now, you can say that that’s OK and Hillary can say that that’s OK. But it’s not OK with me, because based on what she’s saying, and based on where she’s going, and where she’s been, you can take the baby and rip the baby out of the womb in the ninth month on the final day. And that’s not acceptable.

It is simply unconscionable for the Republican Party to stand behind the “scare rhetoric” Trump used as he telescoped the entire complexity of reproductive health rights into a warped and imaginary fight between good and evil, righteousness and sin.

It is the height of hypocrisy to glorify the extraordinary lengths we go to sustain the lives of children who would not otherwise survive without intensive and invasive intervention—often with nontrivial suffering, requiring full-time care that usually falls to mothers and utilizing tremendous societal resources—while reducing heart-wrenching late-term abortion cases to some barbaric and unique act of hubris and interference with God’s will.

With respect to reproductive rights and the American democracy more broadly, I fear for my daughters and for the future of this country when this is the level of rhetoric—reductive, inaccurate, and cruel, predicated on forcing women to bear children against their will—surrounding one of the most important issues of the modern era.


Scroll down for more posts ▼

Top 10 Most Recent News Articles

UST Grabs Italdesign: Driving Future Mobility with AI

Updated Category News Views 2

UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading
Navimow Powers TOP 14 with Tech: A Winning Play

Updated Category News Views 0

A Technological Leap for French Rugby Innovation and precision in partnerships—those words don't usually pop up together when chatting about a rugby league. But here we are, discussing the TOP 14, the elite French rugby championship, pairing up with Segway Navimow. This brand, under the umbrella of Ninebot Limited (689009.SH), is stepping into the world of sports for...

Continue Reading
Rznomics Unveils Breakthrough in Circular RNA Production

Updated Category News Views 1

Decoding the RNA Revolution Ever heard of circular RNA (circRNA)? This ain't your typical strand of genetic code. Unlike their straight-laced, linear counterparts, these RNAs form a loop you can't just break. Picture them as the Kevlar vests of the RNA world—tough, resilient, and packing the promise of next-gen treatments in their covalent loops. Here we’ve got...

Continue Reading
XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 3

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
Ping An Climbs Sustainability Ladder, Scores A+ Rating

Updated Category News Views 2

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

Continue Reading
BYD's Chip Mastery Amid China's Auto Supply Tensions

Updated Category News Views 2

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

Continue Reading
CelluPro Earns Global Recognition with EXCiPACT Certification

Updated Category News Views 1

Breaking New Ground with EXCiPACT Certification Here's a tale unfolding in the high-stakes world of biotechnology—CelluPro, a standout in cell culture media, just snagged the EXCiPACT™ certification. This isn't just some fancy plaque for the wall. It's a stamp of approval that screams reliability in the global biomanufacturing supply scene. Why This Certification...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading

Top 5 Most Recently Viewed Articles

Alert: Red Cat Holdings Investors Consider Legal Action for Losses

Updated Category News Views 163

Overview of Recent Developments for Red Cat Holdings, Inc. Red Cat Holdings, Inc. (NASDAQ: RCAT) has been a topic of discussion among investors, particularly those who purchased securities within a designated period. Several developments have affected the company's stock price, creating an urgent situation for those who might have incurred financial losses. Company...

Continue Reading
Milestone Scientific Reports Strong Growth in Q3 Revenue

Updated Category News Views 128

Milestone Scientific Reports Impressive Revenue Growth for Q3 Addresses remarkable growth in international dental sales and ongoing expansion in pain management technology. Milestone Scientific Inc. (NYSE: MLSS), a forefront player in the development of advanced computerized drug delivery systems for precise and pain-free injections, has delivered promising financial...

Continue Reading
Rio Tinto's Plans for 7% Production Growth by 2025 Explained

Updated Category News Views 205

Rio Tinto's Strategic Overview Rio Tinto Plc (NYSE: RIO) has unveiled its ambitious strategy during a recent Capital Markets presentation aimed at achieving leading industry returns. The company is aligning its focus towards key commodities such as iron ore, copper, aluminium, and lithium, while ensuring heightened safety and productivity across all operations. Production...

Continue Reading
Understanding Elis's Capital Structure and Voting Rights Disclosure

Updated Category News Views 271

Overview of Elis's Capital Structure Elis is a prominent player in the service sector, particularly known for its textile and hygiene solutions. Recently, the company made an important disclosure concerning its capital structure and the total number of voting rights. This information is essential for shareholders and potential investors who wish to understand the...

Continue Reading
Bavarian Nordic Board Endorses Enhanced Takeover Offer

Updated Category News Views 235

Bavarian Nordic Board's Support for Increased Takeover Offer In a decisive move, the Board of Directors of Bavarian Nordic has reaffirmed its recommendation regarding the voluntary public takeover offer proposed by Innosera ApS. The consortium led by Nordic Capital and Permira is now offering an enhanced price for shareholders, marking a significant development for the...

Continue Reading